Figure 1. Schematic representation of the generation of EBV-specific T cells using E1-LMPpoly for adoptive therapy in NPC patients. PBMC are purified from 200-400ml of patient peripheral blood, stimulated with the adenoviral vector encoding E1-LMPpoly and incubated for 14 days in the presence of interleukin-2. Following microbiological testing, the E1-LMPpoly T cells are ready to be reinfused into the patient within 4 weeks after the blood is drawn.